AHS'l'KA(:I'. Pseudomonas aeruginosu is the principal pulmonary pathogen in patients with cystic fibrosis. )ill attempts to date to prevent o r eradicate P. ueruginosa infections in these patients have been unsuccessful. Vaccination against P. aeruginosu has been proposed a s a preventive strategy but it has not been adequatelj evaluated. 'l'he purpose of this study was to determine whether 1'. aeruginosu, present in the lungs of patients with cystic fibrosis, express surface antigens similar to those grown in vitro; this issue is of critical importance when choosing bacterial products a s vaccine candidates. 1,ung sections from two patients who died of the pulmonary complications of cystic fibrosis were studied. Racteria, both in lung sections and isolated from the lung sections and grown in vitro, reacted strongly with polyclonal and monoclonal antibodies against P. aeruginosa mucoid esopolysaccharide and outer membrane proteins 1' and 112; this suggested that these antigens are surface exposed in vivo. It was also found that bacteria in both lung sections were associated in situ with IgG, IgA, and C3 but not with IgR. 1 ( I ) . Although 1'. irc1r.r~i~io.\a is thought to be the principal ('F bacterial pathogen. man! cluestions regarding its role in the disease process remain unanswered. T h e unique host-parasite relationship in the C'F lung is char-act e r i~e d by chronic inkction that ultimately leads to fatal pulKccc~vcd I.cl~l-uar-) -13. IOX7. acccplctl Augclrt 13. 19x7 ('orrcsl)ondcncc. ;ind rcpl-1n1 rctluc\t\ I)r I)a\~(l 1' . Spcci-t. Rcscai-cli ('cntrc. #304-050 Wc\t 28th Avcnuc. Vancouvcl. I3. C'. ('anad; l. VSZ JI 13. Suppo~tcd hi. a grant to [).I'.S li-om ~l i c ('anadl;lii ('ystlc 1.1hn)sis I oundat~oii. 10 l<.l:.W.II hy ;I Mccllcal I<c\carcli ('ouncll ol'('an;ltla grant. and to ii.H.1'. b! ;I grant li-om the Nation;~l Illst~tutc\ ol' Allcrg) anti Inii'ct~ous I)i\ca\cs. I).f'S IS ;I scholar of ~h c i an;ldi;~n ('y\tlc f.ihi-o\l\ I -o~i n d a t~o n ;ind Ci.R.I' IS a Rcseaich Scholar o f t h c 1J S. ('ystlc I .~h r o s~\ I.oilndalion. monar) insufficiency, T h e progr-cssi\c infection c\ol\cs despite the presence o f high levels of anti-1'seudomon:il imn~ilnoglobu-tins in serum and sput~lnl. I'ilr-111er1iio1-c. CF Iiost cjcli'nses ;~ppe;ir to be largely intact (2) . and ('F phagocltic ccll function in essentially normal (2) . Ho\vc\.cr. serum 2nd sputum anti-l'scudomonal IgCi may be deficient in the F-c pol-tion (1). Consccluently. it has bcen suggested that these molecules lack the capacity to opsonire Pseudomonas ti)r ingestion b! al\colar macrophages (3) . We were recently presented ~vith the opport~~nit! to c\aluatc antigens expressed by bacteria prcscnt I I I villi in tlie Iirngs of.t\vo patients with CF. Both patients died :IS the result 01' chronic progressive pulmonary diseuse and had postrnortcm cxaminations. We compared their bacteria grown I~I \.i/t.o and Ix.cscnt iii \ill, in lung sections in :crms of^-taction with antibodies dirccted against specific P. iiclr. ~gitio\ri surface components. Wc also in~estigated the nature of the immi~noglobulin present o n the bacteria in these lung sections. 1 ' 1 1~ obscr-v;ltior~s fj.o~ii tllCsc studies form the basis ofthis rejx>r-t.
( '(I\(, /~i.s/or.io.\ f'iiir(,~ii I . ,411 E;lst Indian girl was diagnosed as liaxing CF in the neonatal period by tlic sel-urn i~n r n~~n o r e a c t i \ c trq psin tcst. J'his uras confirmed 131 a si\.eat clilor-idc of' I 04 :1rlc1 a sweat sodium of 74 mEq/litcr. 1-Ier initial problems ~verc associated with gastroesophageal I-ctlu\ that I'~ilcti to responti to medical o r surgical therapy. She de\clopcci persistent and progressi\.c pulmonary infiltrati\.c disease that \vas prohal~l! cxacer-bated by aspiration of gastric contents. C L I~~L I I -c of her-throat lil-st gren I ' c c~~i r i o t~~o t~i~~ ~lictIio~~/~ilicc at 1 3 months of age. 1' cii,r.lgii~o.\.n was first reco\.ered tiom a throat c~~l t u r c at -30 months of age. Both organisms persisted in her r-csl)ir;~tol.! ~C C~~C~~O I I S until the time of death. She rccei\.cd milltiple course\ ol'antibi-from patient I (Iritrc, I ) . Irnmunoblotting anal!.sis after Western transfer of the SI~S-I'A(;I:-scpar:~tccI proteins tlcmonstrated that all Ibur 1'. trc,rr/,yitro.sri strains hacl proteins that rcactcti \\itti monoclonal antibodies directed against proteins f: and IJ2 (Fig.  I) . Similar-protein antigens wcrc not demonslrablc on the 1'. tn~illo~)/rilit~ isolate.
'fhc I' ric,rii,yit1ovci isolates were assessed with regard to their I.PS plicnotypc. Strains ('l271C'and ('1272(' wcrc both nonthpablc (using the 1)ifco serotyling scheme). ('I2XONh4 anci (' 1205M were both polyagglutinat~le. '1-he f i~u r strain\ wcrc f i~u n d to be scruni sensitibc by the two methods utili/cd. 7'lic t\\o nontylxiblc strains hacf a lower ratio of' smooth to r o u~h 1.1' s than our standard ( 14) laboratol-4 strain of I' rrc,t.lyitio.\ci. I 1 103. when run on SI>S-I'A(;II and stained with silver periodate. .I'lic polyagglutinablc isolates had al,l)rosirnatcl\. thc samc ratio of' smooth to I-ongh 1.1' s when compared with strain 11 103. IgA. arid ('3. f.1lc.1-c n a s minirnal fluorescence nith antiserum to IgM and none nit11 I l u o r c \~~~i natcd antiLC'3. The non-(-F control lung tissi~c Ihilccl to Iluol.cxcc nitli a n ) of the antisern.
I'he host-parasite relationship c1iaracte1-istic o l '~~u l m c~n a r ! iniixtions in patients with ('IF is unicli~c ( 1 . ?. 15). hlucoicl stl-ailis of I' ric,rli,yitro.sri. \vhicIi arc li-cclucntl! c\;tremcl!. susccl~tiblc to the bactericidal eft'cct of human s c r~~r i i ( 14. 16. 17) . chtahlisli a chronic bronchitic infection. Once c.oloni/ation is estahlislicd. these bacteria are \i~-tunll! irnpos<ihlc to cratlicati' ( I ) . I'he chronic infectious process e\,ol\-cs in the prescncc ol'an e \~~l > c r a n t h~lrnoral immune response (7. 18. 10 ) and a n intact ~)li:~~oc!tic host deknsc system (2) . All attempts at medical intcr\cntic~ri to date have fililcd to prc\,ent or cradicatc tlicse ititlolc~it inli'ctioris.
I'hc control o f M P P protii~ction b> ('1-I' i i c~~. i~: . i t i i~\ i i isolate\ is ~~n d e r s t o o d poorl!.. It is not k n o \ \ n \\h!. thesc stratns arc \ir-tuall! u n i q~~c to ('F patients and \\hat tlic [I-iggcr i . ; 1;)s production of M E P In the (' 1: tuns. \\'c h a \ c sIio\\n pl-i~iol~sl!. and confirm herein. that MI:P is pr-csent on nonm~tcoicl :IS \\,ell as mucoid colonial \ariants ( 7 0 Iiiirc, I) ). and I' ~~rii/lol~/i~/ici ~wlatc ( 17'3(' (iii~rc' 1). 1 . 1 1~ \\'c\lc1.11 ~i~i r n u~~o l~l o l on tlic /(,/I was tr-catctl wltll monoclonal antil1otl) M A 1-0. \pcc~iic I k~r -I' ric't.i!:,iiii~\ci lil)oprotc~n f17 (6) . and tllc I>iot o n the r-i:./il \\a\ trcatcti \\it11 monoclonal antihod!, MAS-8. \pccllic li,r 1' . (ic2r-iiyi/io\(i outcr. rnenihranc l,rotcii~ F (7). Small d~fk~.cnccs In Ioati~ng accounted li)r thc di1'1~ic~11cc~\ i i i rcactlvlty o n the Wc\tcrn immunohlot\ (22) previously demonstrated that Pseudomonas strains from the sputum of CF patients were coated with IgA, IgG, IgM, and C3. Our results using direct immunofluorescence examination of lung sections agreed in part with these data by showing that the bacteria in lung sections from both CF patients were associated with IgG, IgA, and C3 (Table 3) . However, despite the presence of such antibodies in established infections, it can be argued that if opsonizing and/or bactericidal antibody could be elicited prior to pulmonary infection, the devastating pulmonary complications of CF might be prevented or at least forestalled. For immunization to be successful, elicited antibody must recognize surface-exposed bacterial epitopes. The purpose of the studies reported herein was to demonstrate whether or not bacteria present in the CF lung have surface-exposed antigens that are recognized by antibodies raised in vitro against purified P. aeruginosa products.
We have demonstrated in these studies, that in the cases studied, P. aeruginosa strains in the CF lung have at least some antigenic similarities to those grown in vitro. Monoclonal and polyclonal antibodies raised against purified P. aeruginosa MEP and outer membrane proteins F and H2 bound to the surfaces of bacteria present in lung tissue from patients with CF. These data are consistent with observations that antibodies to these bacterial products are present in the sera of patients colonized with P. aeruginosa (9, 23, 24) . Thus, there is some potential for using immunotherapy with these antigens to prevent pulmonary coloni~ation with I-'. uc~rlr,yino.su of CF paticnts. For this approach to work, it will probably be nccessa~-y to initiate immunothcrapy before the first lower respiratory tract infection is established. The high levels of anti-Pseudomonas antibodies in the serum of infected CI-paticnts apparently do littlc or nothing to cnhancc clearance of the pathogen. Appropriate vaccinc candidates should bc I ) broadly reactive with multiple I-'. (ic>rll<yino.cu isolates.
2 ) directed against surface exposed cpitopes, and 3) opsonic.
MEP and proteins F and H2 appear to satisfy all these criteria.
In addition, all three antigens are expressed by I-'. (i~~rlr,yinovri isolates grown in .sirlr in the CI-lung. Further investigations with thesc immunogens arc in progress.
A c~/~n o~~l c~y i n c t~~. \ .
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